BRAF and melanoma: This is a retrospective analysis that included 161 patients with BRAF V600E or neuroblastoma RAS viral oncogene homolog (NRAS) pQ61L/K mutated melanoma in primary tumor and in which the presence of the same mutations in ctDNA was analyzed within 12 weeks after surgery using dPCR.